COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...

Arthur Klausner to speak at Biotech & Life Science Global Venture Congress 2006 in New York City
News | 09. 14. 2006